The circulating adhesion molecules sICAM-1 and sE-selectin in patients with sepsis

被引:5
作者
Egerer, K
Rohr, U
Krausch, D
Kox, W
机构
[1] Klin. F. Anaesthiol. I., Univ. Klin. Charité, Humboldt-Universität Berlin
[2] Univ. Klin. F. Anaesthiol. I., Univ. Klin. Charité, Humboldt-Universität, D-10098 Berlin
来源
ANAESTHESIST | 1997年 / 46卷 / 07期
关键词
sepsis; circulating adhesion molecules; sICAM-1; sE-selectin;
D O I
10.1007/s001010050442
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Aim: The aim of this study was to investigate whether the plasma levels of the circulating adhesion molecules sICAM-1 and sE-selectin could serve as early predictors of developing sepsis and its severity. Methods: Twenty-four patients admitted to an intensive care unit with a high risk of developing septic complications were enrolled in this study. Patients were divided into three groups: group I,with infection without systemic sepsis, n = 8; group II, surviving patients with severe sepsis and multi-organ failure (MOF), n = 8; and group III, nonsurviving patients with severe sepsis and MOF, n = 8. Classification of patients was performed according to the clinical criteria defined by the Sepsis Consensus Conference in 1992. Blood samples were taken at 7 a.m. starting from the day of admission until the 7th day after diagnosis of sepsis. Plasma levels of sICAM-1 and sE-selectin were determined in all samples taken between the 3rd pre-septic day and the 7th day after the diagnosis of sepsis was made. Results: In group I, both sICAM-1 (354.21 +/- 128.60 ng/ml, 86 samples) and sE-selectin (30.41 +/- 7.20 ng/ml, 86 samples) levels remained within the reference range over the whole period of observation. The sICAM-1 levels of group II (between 550.82 +/- 275.67 ng/ml and 445.08 +/- 243.63 ng/ml) tended to show values above the reference range without being significant. Mean sICAM-1 levels in group II did not differ from those of group I. From the 2nd pre-septic day onwards the sICAM-1 levels of group III increased, but not significantly. Significant differences in sICAM-1 levels between group I and group III were observed, with peaks at the samples of the 2nd pre-septic day and after the 3rd day of sepsis, respectively (P < 0.05). The sE-selectin levels in group II were elevated from the 3rd pre-septic day onwards, with a peak value on the 2nd day of sepsis (P < 0.05). Afterwards, levels decreased to initial values despite ongoing sepsis. Mean values of sE-selectin levels of group I and II were significantly different with the onset of sepsis (P < 0.05). Plasma levels of sE-selectin in group III were significantly elevated (66.30 +/- 9.00 ng/ml on the 3rd pre-septic day), reaching their maximal values of 106.67 +/- 21.66 ng/ml at the end of the observation period. Significant differences between sE-selectin levels of groups I and III existed from the 3rd pre-septic day onwards, and between group II and III on the 7th and 8th day of sepsis. Conclusion: Our results show that sICAM-1 is a relatively non-specific indicator for sepsis. In contrast, sE-selectin seems to be a good and early predictor of the beginning of severe sepsis with MOF. Furthermore, sE-selectin levels seem to have a prognostic value for the severity, possible course, and outcome of developing sepsis.
引用
收藏
页码:592 / 598
页数:7
相关论文
共 21 条
[1]  
BEVILAQUA MP, 1987, P NATL ACAD SCI USA, V84, P3238
[2]  
COTRAN RS, 1990, J AM SOC NEPHROL, V1, P225
[3]   INCREASED CIRCULATING ADHESION MOLECULE CONCENTRATIONS IN PATIENTS WITH THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - A PROSPECTIVE COHORT STUDY [J].
COWLEY, HC ;
HENEY, D ;
GEARING, AJH ;
HEMINGWAY, I ;
WEBSTER, NR .
CRITICAL CARE MEDICINE, 1994, 22 (04) :651-657
[4]   SOLUBLE FORMS OF VASCULAR ADHESION MOLECULES, E-SELECTIN, ICAM-1, AND VCAM-1 - PATHOLOGICAL SIGNIFICANCE [J].
GEARING, AJH ;
HEMINGWAY, I ;
PIGOTT, R ;
HUGHES, J ;
REES, AJ ;
CASHMAN, SJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 667 :324-331
[5]   CIRCULATING ADHESION MOLECULES IN DISEASE [J].
GEARING, AJH ;
NEWMAN, W .
IMMUNOLOGY TODAY, 1993, 14 (10) :506-512
[6]  
HARNING R, 1991, CANCER RES, V51, P50003
[7]   CIRCULATING ICAM-1 IN NEONATAL SEPSIS [J].
KUSTER, H ;
DEGITZ, K .
LANCET, 1993, 341 (8843) :506-506
[8]  
LOBB RR, 1991, J IMMUNOL, V147, P124
[9]  
MCEVER RP, 1991, THROMB HAEMOSTASIS, V65, P223
[10]  
*MEMB AM COLL CHES, 1992, CRIT CARE MED, V20, P864